Medicare and weight-loss medicine
The Medicare GLP-1 Bridge, explained simply.
From July 1, 2026, through December 31, 2027, a temporary Medicare program covers certain GLP-1 medicines for weight loss for $50 a month, for people who qualify. Here’s who qualifies, which health conditions count, and how to get started.
MD Care is not affiliated with Medicare or CMS. This page is general information, not a coverage decision. Medicare decides coverage, and your clinician decides whether a medicine is right for you.
- Cost
- $50 for a one-month supply
- When
- July 1, 2026, through December 31, 2027
- You need
- Medicare drug coverage (Part D) and Medicare's approval
- Where
- Nationwide, including Florida
Do I qualify?
You may qualify if you match one of these three.
You also need to be 18 or older and have Medicare drug coverage through an eligible plan. BMI is your body mass index, worked out from your height and weight.
Option 1
BMI 35 or higher
That’s enough on its own.
Option 2
BMI 30 or higher
plus at least one of:
- Heart failure with preserved ejection fraction (also called diastolic heart failure)
- High blood pressure that stays above 140/90 even while taking two blood pressure medicines
- Chronic kidney disease, stage 3a or higher
Option 3
BMI 27 or higher
plus at least one of:
- Prediabetes
- A past heart attack
- A past stroke
- Peripheral artery disease (blocked arteries in the legs or arms) that causes symptoms
Good to know
- Medicare uses your BMI from when you first started a GLP-1 medicine. If you started one before July 2026 and paid on your own, your starting BMI is what counts, even if your weight is lower now.
- Your clinician must prescribe the medicine for weight reduction together with a nutrition and activity program.
Who doesn't qualify
Not eligible? Another route may cover you.
Some people are left out of the Bridge because their regular Medicare drug plan can cover a GLP-1 for them instead.
You already get a GLP-1 medicine covered by your Medicare drug plan.
Keep getting it through your plan. CMS says anyone who received a GLP-1 through their Part D plan during 2026 is not eligible. CMS has not yet said how far back it will look in 2027.
You have type 2 diabetes.
Your Medicare drug plan may cover a GLP-1 for this. Ask your plan and your clinician.
You have moderate-to-severe obstructive sleep apnea.
Your Medicare drug plan may cover a GLP-1 for this.
You have the liver condition MASH (fatty liver disease with moderate to advanced scarring, without cirrhosis).
Medicare.gov says "fatty liver disease". CMS forms specify MASH with moderate to advanced scarring. Your drug plan may cover a GLP-1 for this.
The medicine is being prescribed to lower the risk of heart attack, stroke, or heart-related death in someone with established heart disease.
That use goes through your regular Medicare drug plan, not the Bridge. Having had a heart attack or stroke can still count toward the Bridge when the medicine is prescribed for weight.
You are in a plan type that is not eligible, or you have no Medicare drug coverage.
See the eligible and non-eligible plan types further down this page.
You switch to getting a GLP-1 through your drug plan, or move to an ineligible plan type, after Bridge approval.
Your next Bridge refill would be rejected at the pharmacy.
Your regular drug plan
When your Medicare drug plan can cover a GLP-1.
By law, Medicare drug plans do not cover medicines when they are used only for weight loss. They can cover the same medicines when they are prescribed for another FDA-approved use, such as type 2 diabetes. Each plan has its own list of covered drugs, costs, and approval rules.
Type 2 diabetes
Medicare drug plans can cover GLP-1 medicines to treat type 2 diabetes. People with type 2 diabetes are not eligible for the Bridge. Your plan's drug list and approval rules apply.
Medicine: semaglutide, tirzepatide, dulaglutide, liraglutide. Source
Lowering the risk of heart attack, stroke, or heart-related death in adults with established heart disease and obesity or overweight
CMS says people prescribed semaglutide for this use should keep getting coverage through their Medicare drug plan. FDA approved this use in March 2024 (injection), and it is also on the tablet label.
Medicine: semaglutide. Source
Moderate to severe obstructive sleep apnea in adults with obesity
CMS says people prescribed tirzepatide for this use should keep getting coverage through their Medicare drug plan. FDA approved this use on December 20, 2024.
Medicine: tirzepatide. Source
MASH: liver inflammation from fat buildup with moderate to advanced scarring, without cirrhosis
CMS lists this as eligible for Part D coverage. FDA approved semaglutide injection for it in August 2025 under accelerated approval (continued approval may depend on a confirming study).
Medicine: semaglutide. Source
Which medicines
Medicines and plans included.
Exactly as Medicare lists them. The list may be updated during the program.
| Medicine | Form | Included |
|---|---|---|
| orforglipronFoundayo® | Tablet (taken by mouth) | All formulationsAdded April 6, 2026, after FDA approval (April 1, 2026). |
| semaglutideWegovy® | Injection or tablet | All formulations, including Wegovy HD injection (listed on the CMS prior authorization form) |
| tirzepatideZepbound® | Injection, KwikPen only | KwikPen only. Single-dose vials and single-dose pens are NOT covered.Pen needles are not covered and must be bought separately. |
Eligible plan types
- A standalone Medicare drug plan (PDP)
- A Medicare Advantage plan with drug coverage (MA-PD) that is an HMO, HMO-POS, or Local or Regional PPO
- A Special Needs Plan (including D-SNP, C-SNP, and I-SNP)
- An employer or union group retiree plan with Part D (EGWP)
- The Limited Income Newly Eligible Transition (LI NET) program
Not eligible
- Private Fee-for-Service (PFFS) plans
- Medicare cost plans
- Health care prepayment plans
- PACE (Program of All-inclusive Care for the Elderly)
- Fallback plans and religious fraternal benefit plans
People in these plan types are not eligible unless they also have a standalone Medicare drug plan, where that applies. Original Medicare (Parts A and B) with no drug plan does not qualify. Joining a drug plan is only possible at certain times of year.
How to get it
Step by step.
- 1Talk with your clinician about whether a GLP-1 medicine is right for you and whether you might qualify. You can also use the checker at medicare.gov/glp1bridge.
- 2If it is right for you, your clinician sends a prescription to your pharmacy.
- 3Your pharmacy may ask for your Medicare Number, or the last 4 digits of your Social Security Number to look it up.
- 4The pharmacy sends the claim to the Bridge. If approval is needed, the pharmacy asks your clinician to fill out a prior authorization form (usually within 24 to 72 hours).
- 5Your clinician completes the form and confirms you meet the rules and are using the medicine with a diet and exercise program.
- 6A decision is usually made within 72 hours of the form being sent. Medicare mails you a letter, and your clinician is notified.
- 7If approved, pick up your medicine and pay $50 for a one-month supply. Refills and dose changes do not need a new approval unless you switch medicines.
- 8Questions about eligibility or the status of an approval: call 1-800-MEDICARE (1-800-633-4227), TTY 1-877-486-2048.
The fine print
Program rules.
- You pay $50 for a one-month supply (28 or 30 days, depending on the medicine).
- The $50 does not count toward your Medicare drug plan deductible or yearly out-of-pocket limit.
- The $50 does not appear on your Part D Explanation of Benefits or on a Medicare Summary Notice.
- Extra Help (the Medicare program that helps people with limited income pay drug costs) cannot lower the $50.
- The Medicare Prescription Payment Plan cannot spread the $50 across months.
- Manufacturer coupons and discount programs cannot be used to lower the $50.
- Only one-month fills. 60-day or 90-day fills are not available.
- No replacement for lost or stolen medicine.
- Pen needles are not covered by the program. You can buy them separately.
- Your clinician must say the medicine is for weight reduction, used together with a diet and exercise (lifestyle) program.
- Approval (prior authorization) lasts through December 31, 2027, including refills and dose changes, unless you switch to a different GLP-1 medicine.
- There is no appeals process in the program. Your clinician can resubmit the form with corrected or new information.
Also covered by Medicare
Help with weight that isn't a medicine.
Obesity screening and behavioral counseling
BMI of 30 or more. Counseling must come from a primary care provider in a primary care setting, like a doctor's office. You must meet certain weight-loss requirements for coverage to continue.
$0 if your primary care provider accepts assignment.
Medicare.govMedicare Diabetes Prevention Program
BMI of 25 or more (23 or more if you are Asian), a blood sugar test in the prediabetes range within the past 12 months, and no past diagnosis of type 1 or type 2 diabetes or end-stage kidney disease. Offered by approved program suppliers in person, live online, or self-paced online.
$0 if you qualify.
Medicare.govDiabetes self-management training
Diagnosed with diabetes, with an order from your clinician. Up to 10 hours the first year, then up to 2 hours of follow-up each year.
After the Part B deductible ($283 in 2026), you pay 20% of the Medicare-approved amount.
Medicare.govMedical nutrition therapy (with a registered dietitian)
Diabetes or kidney disease, or a kidney transplant in the last 36 months, with a doctor's referral. 3 hours the first year, then up to 2 hours each year after.
$0 if you qualify.
Medicare.govOffice and telehealth visits with your clinician
Medically necessary visits, including for weight-related conditions. Medicare covers telehealth from home anywhere in the U.S. through December 31, 2027.
After the Part B deductible ($283 in 2026), usually 20% of the Medicare-approved amount. Medicare Advantage costs vary by plan.
Medicare.govWhat happens after December 31, 2027?
BALANCE is a separate CMS model for GLP-1 coverage. Its Medicare drug plan part will not start in 2027. CMS has delayed it while it gathers more information and extended the Bridge through December 31, 2027 instead. There is no BALANCE coverage for people with Medicare today.
FAQ
Questions about the Bridge.
Does Medicare cover GLP-1 medicines for weight loss?
Usually, Medicare drug plans can't cover medicines used only for weight loss. From July 1, 2026, through December 31, 2027, a temporary Medicare program called the Medicare GLP-1 Bridge covers certain GLP-1 medicines for weight loss for people who qualify. You pay $50 a month.
Who qualifies for the Medicare GLP-1 Bridge?
You need to be 18 or older and have Medicare drug coverage through an eligible plan. Your BMI when you started the medicine must be 35 or higher. It can also be 30 or higher with certain heart, blood pressure, or kidney conditions, or 27 or higher with prediabetes, a past heart attack or stroke, or leg or arm artery disease that causes symptoms. Your clinician checks this and decides whether the medicine is right for you.
Who does not qualify?
You don't qualify if your Medicare drug plan already covers a GLP-1 for you, or if you have type 2 diabetes, moderate-to-severe sleep apnea, or the liver condition MASH. Your drug plan may cover a GLP-1 for those conditions instead. People with no Medicare drug coverage, or in certain plan types such as Private Fee-for-Service, cost plans, or PACE, also don't qualify.
I have a Medicare Advantage plan. Does the Bridge apply to me?
It can. Medicare Advantage HMO, HMO-POS, and PPO plans that include drug coverage are eligible, and so are Special Needs Plans. Private Fee-for-Service plans are not. The Bridge runs separately from your plan, and Medicare handles the approval, not your plan. If you aren't sure what type of plan you have, call 1-800-MEDICARE.
What does the $50 cover, and does it count toward my drug plan costs?
The $50 pays for a one-month supply (28 or 30 days, depending on the medicine). It doesn't count toward your drug plan deductible or yearly out-of-pocket limit. Extra Help doesn't lower it, coupons can't be used, and the Medicare Prescription Payment Plan can't spread it out. Fills are one month at a time.
Which medicines are included?
Certain forms of semaglutide (injection or tablet), tirzepatide (one pen type only), and orforglipron (tablet). Not every form of each medicine is included. Your clinician and pharmacy can tell you which ones qualify.
How do I get started?
Talk with your clinician. If a GLP-1 is right for you, your clinician sends a prescription to your pharmacy. When the pharmacy asks, your clinician fills out an approval form. Medicare mails you a letter with the decision. Once you're approved, refills and dose changes don't need a new approval unless you switch medicines.
I already pay for a GLP-1 on my own. Can I switch to the Bridge?
Possibly. If you've been paying on your own instead of through your Medicare drug plan, you may qualify. Medicare uses your BMI from when you first started the medicine. Your clinician can help you check.
What if I have type 2 diabetes, sleep apnea, heart disease, or MASH?
Your regular Medicare drug plan may cover a GLP-1 for some of these FDA-approved uses. Each plan has its own drug list, costs, and approval rules, so check with your plan. Your clinician decides which treatment fits you.
What happens after December 31, 2027?
The Bridge is scheduled to end December 31, 2027, and Medicare hasn't announced what comes next. A separate CMS model called BALANCE won't start in Medicare drug plans in 2027. We'll update this page when Medicare announces more.
Does Medicare cover weight-loss counseling or nutrition help?
Yes, in some cases. Part B covers obesity counseling with a primary care provider if your BMI is 30 or more, at no cost if the provider accepts assignment. If you have prediabetes, the Medicare Diabetes Prevention Program is free if you qualify. People with diabetes or kidney disease may qualify for nutrition therapy with a dietitian.
Is MD Care part of Medicare?
No. MD Care is not affiliated with Medicare or CMS. We are a Florida telehealth practice. For official answers about your eligibility, visit medicare.gov/glp1bridge or call 1-800-MEDICARE (1-800-633-4227), TTY 1-877-486-2048.
Sources (checked October 26, 2026)
- Medicare.gov: Weight loss drugs (Medicare GLP-1 Bridge)
- Medicare.gov: Weight loss drugs (same page, alternate URL)
- Medicare.gov fact sheet: Medicare GLP-1 Bridge, GLP-1 Drugs for $50 a Month (CMS Product No. 12234, June 2026)
- CMS: Medicare GLP-1 Bridge
- CMS: Medicare GLP-1 Bridge, Information for Providers
- CMS: Medicare GLP-1 Bridge, Information for Pharmacies
- CMS: Medicare GLP-1 Bridge, Information for Part D Plans
- CMS memo (June 10, 2026): Medicare GLP-1 Bridge Expectations and FAQs for Part D Sponsors
- CMS: Medicare GLP-1 Bridge Prior Authorization Request Form
- CMS memo (April 21, 2026): Status Update on the Bridge Demo and BALANCE Model in Part D for CY2027
- CMS press release (July 1, 2026): CMS Launches Medicare GLP-1 Bridge
- CMS: BALANCE Model
- CMS: Medicare Prescription Drug Benefit Manual, Chapter 6 (excluded drugs)
- Medicare.gov: Obesity behavioral therapy
- Medicare.gov: Medicare Diabetes Prevention Program
- Medicare.gov: Diabetes self-management training
- Medicare.gov: Medical nutrition therapy services
- Medicare.gov: Doctor and other health care provider services
- Medicare.gov: Telehealth
- Medicare.gov: Medicare costs (2026)
- FDA (March 8, 2024): semaglutide injection approved to reduce heart risks in adults with obesity or overweight
- FDA (December 20, 2024): tirzepatide approved for obstructive sleep apnea
- FDA (August 2025): semaglutide approved for MASH
- FDA (April 1, 2026): orforglipron approved
- FDA (March 19, 2026): higher-dose semaglutide injection approved
- FDA label: semaglutide injection and tablets for weight (revised 02/2026)
- FDA label: tirzepatide for weight and sleep apnea (revised 01/2026)
- FDA label: orforglipron (revised 07/2026)
- FDA label: semaglutide for type 2 diabetes, including kidney use (revised 10/2025)
Official help: 1-800-MEDICARE (1-800-633-4227), TTY 1-877-486-2048, or the checker at medicare.gov/glp1bridge. MD Care is not affiliated with Medicare or CMS. This page is general information, not a coverage decision. Medicare decides coverage, and your clinician decides whether a medicine is right for you. Brand names are trademarks of their owners.
Let's see what Medicare can cover for you.
Book a weight-loss consultation by video. We review your eligibility and check your coverage before you start.
Book a consultation